Changes in Alcohol-Related Behaviors and Quality of Life During the COVID-19 Pandemic: Impact of Alcohol Use Disorder Diagnosis and Treatment History.

Autor: Luk JW; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.; Corresponding authors: Jeremy W. Luk, PhD, National Institute on Alcohol Abuse and Alcoholism (NIAAA), Office of the Clinical Director, Bldg 10 - CRC, Room 1-5340, Bethesda, MD 20892 (jeremy.luk@nih.gov); Vijay A. Ramchandani, PhD, National Institute on Alcohol Abuse and Alcoholism (NIAAA), Human Psychopharmacology Laboratory, Bldg 10 - CRC, Room 2-2352, Bethesda, MD 20892 (vijayr@mail.nih.gov)., Stangl BL; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland., Gunawan T; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland., Schwandt ML; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland., Morris JK; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland., Axelowitz JC; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland., Chawla S; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland., Lee BA; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland., Carraco M; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland., Walsh S; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland., McDuffie C; Section of Sensory Science and Metabolism, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland., Agarwal K; Section of Sensory Science and Metabolism, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland., Joseph PV; Section of Sensory Science and Metabolism, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland., Momenan R; Clinical NeuroImaging Research Core, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland., Goldman D; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.; Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, Rockville, Maryland., Diazgranados N; Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.; Equal contribution., Ramchandani VA; Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.; Equal contribution.; Corresponding authors: Jeremy W. Luk, PhD, National Institute on Alcohol Abuse and Alcoholism (NIAAA), Office of the Clinical Director, Bldg 10 - CRC, Room 1-5340, Bethesda, MD 20892 (jeremy.luk@nih.gov); Vijay A. Ramchandani, PhD, National Institute on Alcohol Abuse and Alcoholism (NIAAA), Human Psychopharmacology Laboratory, Bldg 10 - CRC, Room 2-2352, Bethesda, MD 20892 (vijayr@mail.nih.gov).
Jazyk: angličtina
Zdroj: The Journal of clinical psychiatry [J Clin Psychiatry] 2022 Nov 07; Vol. 84 (1). Date of Electronic Publication: 2022 Nov 07.
DOI: 10.4088/JCP.22br14462
Databáze: MEDLINE